article thumbnail

FDA rebuffs Amneal's Parkinson's prospect with $500M peak sales target

Fierce Pharma

Amneal Pharmaceuticals’ hopes for a midyear launch of its extended-release Parkinson’s disease prospect—and a shot at a potential $500 million peak sales opportunity in the U.S.—have

article thumbnail

Fierce Pharma Asia—Takeda's manufacturing expansion; Leqembi's sales prospects; GSK's PrEP generics

Fierce Pharma

Fierce Pharma Asia—Takeda's manufacturing expansion; Leqembi's sales prospects; GSK's PrEP generics aliu Thu, 03/30/2023 - 16:18

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

With M&A Deal, Click Therapeutics’ Digital Prospects in Metabolic Disease Get Better

MedCity News

The post With M&A Deal, Click Therapeutics’ Digital Prospects in Metabolic Disease Get Better appeared first on MedCity News. Click Therapeutics is acquiring the assets of Better Therapeutics two months after that digital therapeutics developer announced it would lay off all employees and shut down.

article thumbnail

Ardelyx FDA docs portend another showdown at this week's expert hearing on kidney disease prospect

Fierce Pharma

Ardelyx FDA docs portend another showdown at this week's expert hearing on kidney disease prospect. fkansteiner. Tue, 11/15/2022 - 10:30.

article thumbnail

Best Practices for Accelerating the Sales Process

Think about it: with outbound prospecting, requests from management, scheduled demos, and inbound calls, chaos can quickly work its way into your strategy, deeming a “speed wins” selling mentality downright ineffective. What's covered: Targeted prospecting. The bottom line is that, in B2B sales, speed is useless without control.

article thumbnail

ASCO: Bristol Myers' confirmatory KRAS data avoid Amgen's flaws but still leave FDA prospects unclear

Fierce Pharma

After Amgen’s KRAS confirmatory trial results were rejected by the FDA as uninterpretable, Bristol Myers Squibb has divulged details of its rival study. Bristol Myers Squibb has divulged the details of Krazati's confirmatory trial.

article thumbnail

After 2 rejections, FDA panel rallies around Ardelyx's kidney disease prospect

Fierce Pharma

After 2 rejections, FDA panel rallies around Ardelyx's kidney disease prospect. fkansteiner. Thu, 11/17/2022 - 06:51.

article thumbnail

How Intent Data Helps Marketers Convert A-List Accounts

One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. By tracking buyers’ digital footprints and online activity, such as website visits, product reviews, and spikes in content consumption, you can engage prospects with a message that really resonates.

article thumbnail

The Impact of Direct Dials on Sales Productivity

While dialing away at targeted prospects, it’s important for them to remember that not all sales outreach is created equal. Take the following stats into consideration: It takes 5 minutes to connect with a prospect via direct dials, but takes 22 minutes using company switchboard numbers.

article thumbnail

Buyer’s Checklist: How to Evaluate a B2B Contact Data Provider

Leveraging a data provider to help identify and connect with qualified prospects supports company revenue goals by alleviating common headaches associated with prospecting research and empowers sales productivity. So what’s the problem? Many organizations fail to properly evaluate vendors during the selection process.

article thumbnail

Pressure Points: How to Ensure Your B2B Pipeline Passes Inspection

you’ll see what we mean in this eBook) more revenue through data-driven prospecting, stage analysis, and subsequent sales enablement. This eBook highlights best practices for developing a pipeline management process that helps sales leaders and their team C.L.O.S.E

article thumbnail

3 Sizzling Ways to Warm up Cold Calls

Dig into this eBook to find out how to make cold calling a thing of the past with: Powerful sales engagement and automation Insights, signals, and deep prospect research Alternative touchpoints that keep the conversation alive

article thumbnail

Catch Them If You Can: The Passive Candidates Edition

To get started on your search, we’ve gathered clues you’ll need to get in the mind of your passive prospects. Yet, with the right tools and mindset, it’s possible to track down this candidate - and many others like them! Simple: By thinking like one. It’s time to get out and catch them… if you can!

article thumbnail

The Ultimate Guide to Sales Outreach

In this eBook, we’ll cover: How you should respond to inbound leads Tactics for engaging outbound leads (cold calls, email automation, and gifts) The key to keeping a prospective account alive for the long haul Buckle up! We bring the science—proven tactics, strategies, and methods that really work.

article thumbnail

16 Go-to-Market Plays for Your Entire Sales Funnel

But personalized prospecting is possible at scale with the right resources in place. Nurturing leads through your sales funnel is a daunting task for many business development teams, especially at the scale required to achieve lofty growth goals. At ZoomInfo, we’ve found that a rock-solid go-to-market playbook is key.